Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Highlights
The quick ratio has soared by 63% from the previous quarter and by 38% YoY
Pfizer's equity has increased by 8% YoY
The price to earnings (P/E) is 25% lower than the 5-year quarterly average of 19.6 but 19% higher than the last 4 quarters average of 12.3
Pfizer's EPS has increased by 14% YoY but it has decreased by 10% from the previous quarter
PFE's debt is up by 36% YoY and by 22% from the previous quarter
Pfizer's revenue has decreased by 8% YoY and by 2.9% QoQ
Key stats
What are the main financial stats of PFE
Market
Shares outstanding
5.56B
Market cap
$207.99B
Enterprise value
$269.81B
Valuations
Price to earnings (P/E)
14.68
Price to book (P/B)
3.23
Price to sales (P/S)
4.23
EV/EBIT
15.84
EV/EBITDA
12.03
EV/Sales
5.48
Earnings
Revenue
$49.2B
EBIT
$17.03B
EBITDA
$22.44B
Free cash flow
$12.6B
Per share
EPS
$2.55
Free cash flow per share
$2.27
Book value per share
$11.58
Revenue per share
$8.86
TBVPS
$15.47
Balance sheet
Total assets
$177.93B
Total liabilities
$113.37B
Debt
$63.61B
Equity
$64.34B
Working capital
$13.7B
Liquidity
Debt to equity
0.99
Current ratio
1.42
Quick ratio
0.98
Net debt/EBITDA
2.76
Margins
EBITDA margin
45.6%
Gross margin
79.9%
Net margin
28.8%
Operating margin
18.2%
Efficiency
Return on assets
8.3%
Return on equity
22%
Return on invested capital
18.1%
Return on capital employed
11.7%
Return on sales
34.6%
Dividend
Dividend yield
4.01%
DPS
$1.5
Payout ratio
58.8%
PFE stock price
How has the Pfizer stock price performed over time
Financial performance
How have Pfizer's revenue and profit performed over time
Revenue
$49.2B
Gross profit
$39.33B
Operating income
$8.96B
Net income
$14.17B
Gross margin
79.9%
Net margin
28.8%
The operating income has contracted by 23% YoY and by 2% from the previous quarter
PFE's net margin is up by 22% YoY but it is down by 8% from the previous quarter
The company's operating margin fell by 17% YoY
Pfizer's net income has increased by 12% YoY but it has decreased by 10% QoQ
Growth
What is Pfizer's growth rate over time
Valuation
What is Pfizer stock price valuation
P/E
14.68
P/B
3.23
P/S
4.23
EV/EBIT
15.84
EV/EBITDA
12.03
EV/Sales
5.48
The price to earnings (P/E) is 25% lower than the 5-year quarterly average of 19.6 but 19% higher than the last 4 quarters average of 12.3
Pfizer's EPS has increased by 14% YoY but it has decreased by 10% from the previous quarter
Pfizer's equity has increased by 8% YoY
PFE's P/B is 8% above its last 4 quarters average of 3.0 but 2.1% below its 5-year quarterly average of 3.3
PFE's P/S is 11% above its last 4 quarters average of 3.8 and 6% above its 5-year quarterly average of 4.0
Pfizer's revenue has decreased by 8% YoY and by 2.9% QoQ
Efficiency
How efficient is Pfizer business performance
Pfizer's ROS has soared by 59% YoY
The company's return on invested capital rose by 24% YoY but it fell by 10% QoQ
Pfizer's ROA has decreased by 14% from the previous quarter but it has increased by 5% YoY
The ROE fell by 12% QoQ but it rose by 10% YoY
Dividends
What is PFE's dividend history
DPS
$1.5
Dividend yield
4.01%
Payout ratio
58.8%
Recent dividends
Financial health
How did Pfizer financials performed over time
PFE's total assets is 57% greater than its total liabilities
The quick ratio has soared by 63% from the previous quarter and by 38% YoY
The current ratio has grown by 38% from the previous quarter but it has contracted by 3.4% YoY
PFE's debt is up by 36% YoY and by 22% from the previous quarter
The debt to equity has grown by 27% YoY and by 24% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated
quarterly, unless otherwise specified.